StockData

Drugs Made In America Acquisition Corp. (DMAA) stock

DMAANasdaqBlank ChecksFiscal year ends December 31Also trades as DMAAR, DMAAU
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$10.90+0.00 (0.00%)

Close on Nov 17, 2026Market cap $264.62MP/E –Yield –

Drugs Made In America Acquisition price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

No price to book ratio figures for Drugs Made In America Acquisition

Drugs Made In America Acquisition has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Drugs Made In America Acquisition figures

See a number that looks wrong?